01 6ELI LILLY AND CO
01 6RE50455
01 6Y
01 6Y
01 62037-09-26
Patent Expiration Date : 2037-09-26
US Patent Number : RE50455
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 220934
Patent Use Code : U-4474
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2037-09-26
Patent Expiration Date : 2037-09-26
US Patent Number : RE50455
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 220934
Patent Use Code : U-4474
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2037-09-26
Patent Expiration Date : 2037-09-26
US Patent Number : RE50455
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 220934
Patent Use Code : U-4474
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2037-09-26
Patent Expiration Date : 2037-09-26
US Patent Number : RE50455
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 220934
Patent Use Code : U-4474
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2037-09-26
Patent Expiration Date : 2037-09-26
US Patent Number : RE50455
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 220934
Patent Use Code : U-4474
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2037-09-26
Patent Expiration Date : 2037-09-26
US Patent Number : RE50455
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 220934
Patent Use Code : U-4474
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2037-09-26
